Semaglutide Microdose Injection

GLP-1 Microdosing. Weekly low-dose subcutaneous injection

Sub-therapeutic weekly GLP-1 dosing intended to sustain metabolic benefits with fewer side effects.

Dosing: Low-dose weekly injection, adjusted by a HELiXVi clinician based on response.

Best for: Maintenance-phase patients, patients highly sensitive to GLP-1 side effects, or those exploring a lower-dose protocol.

Key points

• Lower-dose approach designed to minimize GI side effects
• Often used for weight maintenance after primary titration
• Clinician-managed throughout

Considerations

• Evidence base for microdosing is smaller than for standard titration
• Prescription-only, requires clinician review

Prescription treatment requires an online consultation with a licensed HELiXVi clinician. Individual results vary.

Start your free consultation right now

No clinic visit. Licensed US clinicians. Dispatched within 24 hours of your consultation and payment.

See the full weight loss program